U.S. Markets close in 2 hrs 2 mins

pSivida Corp. (PSDV)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.24-0.01 (-0.80%)
As of 1:53PM EDT. Market open.
People also watch
ALIMOPXAPRANRPRXBDSI
Full screen
Previous Close1.25
Open1.27
Bid1.24 x 2600
Ask1.25 x 200
Day's Range1.23 - 1.28
52 Week Range1.03 - 3.30
Volume179,840
Avg. Volume398,496
Market Cap48.82M
Beta-1.82
PE Ratio (TTM)-2.26
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube7 days ago

    ETFs with exposure to pSivida Corp. : September 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • pSivida Corp. :PSDV-US: Earnings Analysis: 2017 By the Numbers : September 15, 2017
    Capital Cube10 days ago

    pSivida Corp. :PSDV-US: Earnings Analysis: 2017 By the Numbers : September 15, 2017

    Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the year ended June 30, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., XOMA Corporation, Abbott Laboratories, Merck & Co., Inc., Heron Therapeutics Inc, Pfizer Inc. and Valeant Pharmaceuticals International Inc ... Read more (Read more...)

  • Thomson Reuters StreetEvents13 days ago

    Edited Transcript of PSDV earnings conference call or presentation 11-Sep-17 8:30pm GMT

    Q4 2017 pSivida Corp Earnings Call